cimadronate has been researched along with Adenocarcinoma, Basal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asahi, H; Komatsu, K; Koshida, K; Maeda, Y; Mizokami, A; Namiki, M | 1 |
1 other study(ies) available for cimadronate and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Bone Neoplasms; Diphosphonates; Drug Resistance, Neoplasm; Drug Therapy, Combination; Estramustine; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms | 2003 |